Rangarajan S - Search Results

1

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO.

Collins P, Chalmers E, Chowdary P, Keeling D, Mathias M, O'Donnell J, Pasi KJ, Rangarajan S, Thomas A. Collins P, et al. Among authors: rangarajan s. Haemophilia. 2016 Jul;22(4):487-98. doi: 10.1111/hae.13013. Epub 2016 Jun 16. Haemophilia. 2016. PMID: 27311929 Review.

2

Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full-length FVIII treatment to B-domain-deleted r-FVIII and back to full-length FVIII.

Rea C, Dunkerley A, Sørensen B, Rangarajan S. Rea C, et al. Among authors: rangarajan s. Haemophilia. 2009 Nov;15(6):1237-42. doi: 10.1111/j.1365-2516.2009.02071.x. Epub 2009 Aug 2. Haemophilia. 2009. PMID: 19664015

3

Von Willebrand factor--two sides and the edge of a coin.

Rangarajan S. Rangarajan S. Haemophilia. 2011 Jan;17(1):61-4. doi: 10.1111/j.1365-2516.2010.02323.x. Haemophilia. 2011. PMID: 20518815

4

Inhibitors of coagulation.

Rangarajan S. Rangarajan S. Haemophilia. 2011 Jan;17(1):90-4. doi: 10.1111/j.1365-2516.2010.02335.x. Haemophilia. 2011. PMID: 20546027 No abstract available.

5

Experience of four UK comprehensive care centres using FEIBA® for surgeries in patients with inhibitors.

Rangarajan S, Yee TT, Wilde J. Rangarajan S, et al. Haemophilia. 2011 Jan;17(1):28-34. doi: 10.1111/j.1365-2516.2010.02360.x. Haemophilia. 2011. PMID: 20642787

6

Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.

Dai L, Bevan D, Rangarajan S, Sørensen B, Mitchell M. Dai L, et al. Among authors: rangarajan s. Haemophilia. 2011 Sep;17(5):e944-8. doi: 10.1111/j.1365-2516.2011.02491.x. Epub 2011 Mar 3. Haemophilia. 2011. PMID: 21371192

7

The international factor IX treatment network survey.

Berntorp E, Shapiro AD, Waters J, Astermark J; International Factor IX Treatment Network. Berntorp E, et al. Haemophilia. 2012 May;18(3):e60-2. doi: 10.1111/j.1365-2516.2012.02767.x. Epub 2012 Mar 8. Haemophilia. 2012. PMID: 22404549 No abstract available.

8

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.

Tengborn L, Baudo F, Huth-Kühne A, Knoebl P, Lévesque H, Marco P, Pellegrini F, Nemes L, Collins P; EACH2 registry contributors. Tengborn L, et al. BJOG. 2012 Nov;119(12):1529-37. doi: 10.1111/j.1471-0528.2012.03469.x. Epub 2012 Aug 20. BJOG. 2012. PMID: 22901076

9

Consensus recommendations for the use of FEIBA(®) in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery.

Rangarajan S, Austin S, Goddard NJ, Négrier C, Rodriguez-Merchan EC, Stephensen D, Yee TT. Rangarajan S, et al. Haemophilia. 2013 Mar;19(2):294-303. doi: 10.1111/hae.12028. Epub 2012 Sep 19. Haemophilia. 2013. PMID: 22989234 Review.

10

Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry.

Chambost H, Santagostino E, Laffan M, Kavakli K; ONE Registry Steering Committee on behalf of the investigators. Chambost H, et al. Haemophilia. 2013 Jul;19(4):571-7. doi: 10.1111/hae.12140. Epub 2013 Apr 5. Haemophilia. 2013. PMID: 23557542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters